USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
The Australian Contract Research Organization Market
The Australian Contract Research Organization Market
Early Phase Clinical Trials are Set to Drive the Australian CRO Market
RELEASE DATE
14-Aug-2015
14-Aug-2015
REGION
North America
North America
Research Code: 9AB9-00-35-00-00
SKU: LS00076-NA-MR_16917
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
LS00076-NA-MR_16917
Description
This research service presents an overview and analysis of the Australian contract research organization (CRO) market. The research service provides market revenue forecasts by phase and therapeutic type and discusses major issues and challenges, unmet needs, and developing trends in the CRO market. The study covers the complete life cycle of the CRO industry, starting from preclinical trials to Phase IV trials and provides detailed information on support services such as central laboratory services, biostatistics, bioanalytics, and data management. The research service analyses market engineering measurements and research and development trends.
Table of Contents
Key Findings
Key Findings (continued)
Total CRO Market Size by Stages of Clinical Development
Market Size Estimation Methodology
Scope and Segmentation
Key Questions this Study will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Key Companies to Watch (continued)
Pharmaceutical Market Overview
Pharmaceutical Market Overview (continued)
Market Perspective
Clinical Trials Market Overview
Clinical Trials Market Overview (continued)
Clinical Trials Scenario
Profiles of Clinical Trials
Total CRO Market Segmentation by Stages of Clinical Development
Forecast Assumptions
Market Engineering Measurements
Total CRO Market—Revenue Forecast
Total CRO Market—Revenue Forecast Discussion
CRO Market—Phase I and Phase II
CRO Market—Phase III and Phase IV
CRO Market—Revenue Forecast for Preclinical Trials
Revenue Forecast Discussion for Preclinical Trials
CRO Market—Revenue Forecast for Data Management
Revenue Forecast Discussion for Data Management
CRO Market—Revenue Forecast for Biostatistics
Revenue Forecast Discussion for Biostatistics
CRO Market—Revenue Forecast for Central Laboratory Services
Revenue Forecast Discussion for Central Laboratory Services
CRO Market—Revenue Forecast for Pharmacovigilance
Revenue Forecast Discussion for Pharmacovigilance
CRO Market—Revenue Forecast for Bioanalytics
Revenue Forecast Discussion for Bioanalytics
CRO Market—Revenue Forecast for HEOR
Revenue Forecast Discussion for HEOR
Total CRO Market—Key Trends
Clinical Research Regulatory Overview
Clinical Research Regulatory Overview (continued)
Clinical Research Regulatory Process
Competitive Structure
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
The Last Word—Discussion
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) market, with particular focus on the antibiotics currently under development. A list of currently available and marketed antibacterial drugs under the approved antibacterial drug classes has been provided. Product and pipeline assessment for recently approved antibacterial drugs, antibacterials under FDA review, as well as phase 3 antibacterial drug candidates have been provided. A detailed overview of the various regulatory approaches to foster innovation in the development of new antibiotics has been provided as well.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Sanjeev Kumar |
| WIP Number | 9AB9-00-35-00-00 |
| Keyword 1 | Contract Organizations |
| Keyword 2 | CROs |
| Keyword 3 | CRO in australia |
| Is Prebook | No |